相关实验视频

Updated: May 11, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

对心肌细胞增殖的药物发现取得了进展

Kaitlyn L Wintruba¹, Matthew J Wolf², Jop H van Berlo³

¹Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908 USA.

Current treatment options in cardiovascular medicine

|July 22, 2025

概括

本综述讨论了用于增加心肌细胞增殖的新药发现方法. 虽然有前临床结果很有希望,但临床翻译面临着挑战,需要对心脏修复机制进行进一步的基础研究.

科学领域:

心血管研究研究心血管研究
药物发现药物发现药物发现
再生医学是一种再生医学.

背景情况:

心肌细胞损失和功能障碍是心力衰竭的核心原因.
刺激心肌细胞增殖为心脏修复提供了一个潜在的治疗策略.
目前的治疗方法主要是治疗症状,而不是促进再生.

研究的目的:

审查针对心肌细胞增殖的药物发现的最新进展.
确定将这些发现转化为临床应用的关键挑战.
突出提高翻译潜力的新兴策略.

主要方法:

使用干细胞衍生或新生儿心肌细胞的高通量查.
采用计算建模和奥米克分析来获得机械洞察力.
包括正交查和跨物种验证.

主要成果:

确定调节增殖信号通路的候选化合物.
获得了机制学理解,以支持有针对性的药物发现.
在动物模型中,在识别刺激心肌细胞增殖的药物方面取得了进展.

结论:

在用于心肌细胞增殖的临床前药物发现方面取得了重大进展.
将这些发现转化为有效的临床疗法仍然是一个挑战.
对心脏修复机制的进一步基础研究对于指导未来药物开发至关重要.

关键词:

心脏再生的心脏再生心肌细胞的增殖和扩散.心血管疾病心血管疾病遗传性心脏病是一种先天性心脏病.药物发现药物发现药物选器可以检查药物.

更多相关视频

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...